You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
福元醫藥(601089.SH):多巴絲肼片獲得藥品註冊證書
格隆匯 06-13 16:08

格隆匯6月13日丨福元醫藥(601089.SH)公佈,收到了國家藥品監督管理局頒發的多巴絲肼片(規格:左旋多巴200mg與苄絲肼50mg(相當於鹽酸苄絲肼57mg))《藥品註冊證書》。多巴絲肼片是羅氏製藥有限公司研發的由左旋多巴和苄絲肼以4:1的比例混合製備的複方製劑,最早於1979年8月在日本獲批上市,2003年3月經國家藥品監督管理局批准,原研地產化多巴絲肼片在國內獲批上市,用於治療帕金森病、症狀性帕金森綜合症(腦炎後、動脈硬化性或中毒性),但不包括藥物引起的帕金森綜合症。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account